Investment Q&A

• Zymeworks Inc. (ZYME $23.17)
  • $23.17 Cap: $1.85B
  • View ZYME Profile
  • View Questions on ZYME

Q: whats your opinion on zymeworks.i have owned it since 15., its doubled;
its results are strong, they have relationships with 8 of the largest pharma companies. It keeps hitting new 52 week highs. i know they will do a fund raise soon, but got thru the last fund raise with ease. . dave

Upvote 0

Read Answer Asked by david on November 25, 2019

• Celgene Corporation (CELG $108.24)
  • View CELG Profile
  • View Questions on CELG
• Bristol-Myers Squibb Company (BMY $55.86)
  • $55.86 P/E (TTM): 18.82X Cap: $113.71B
  • View BMY Profile
  • View Questions on BMY

Q: Good morning team, with my celg shares gone, replaced with bmy and bmy.rt , my question is what to do with the bmy rights. Sell , hold or what will they may be worth in the future? Any thoughts?

Thanks, Michael

Upvote 0

Read Answer Asked by Michael on November 25, 2019

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Yesterday they announced the end of the relationship with Medison . However they ignored the deal with Onconova ONTX.
ONTX had a press release but GUD ignored it.
On Sedar the Medison news is posted but not ONTX. Any insight as to why ? Too small a deal perhaps ?
Thanks

Upvote 0

Read Answer Asked by Luc on November 22, 2019

• Guardant Health Inc. (GH $110.17)
  • $110.17 Cap: $13.88B
  • View GH Profile
  • View Questions on GH

Q: Peter and staff; I have held this stock for a short period of time and it has not produced the results I was looking for. Can you share an opinion and possibly a suggestion going forward?

Upvote 0

Read Answer Asked by John on November 22, 2019

• AMN Healthcare Services Inc (AMN $15.31)
  • $15.31 Cap: $588M
  • View AMN Profile
  • View Questions on AMN

Q: What do you think of AMN as a healthcare holding?

Upvote 0

Read Answer Asked by Kel on November 22, 2019

• Inspire Medical Systems Inc. (INSP $98.38)
  • $98.38 P/E (TTM): 54.29X Cap: $2.85B
  • View INSP Profile
  • View Questions on INSP

Q: Any thoughts on this medical device company?
Offers an FDA approved alternative for those dealing with sleep apnea.

Upvote 0

Read Answer Asked by Wendy on November 21, 2019

• InMode Ltd. (INMD $14.44)
  • $14.44 Cap: $1B
  • View INMD Profile
  • View Questions on INMD

Q: any idea why stock is down on big volume?

Upvote 0

Read Answer Asked by hal on November 21, 2019

• BioSyent Inc. (RX $12.87)
  • $12.87 P/E (TTM): 17.16X Cap: $147M
  • View RX Profile
  • View Questions on RX
• HLS Therapeutics Inc. (HLS $4.79)
  • $4.79 Cap: $149M
  • View HLS Profile
  • View Questions on HLS

Q: your thoughts on recent Q3 results. worth sticking with this company or can you suggest alternative investment.
thanks
Don

Upvote 0

Read Answer Asked by Don on November 21, 2019

Q: Hello 5i , could I have your comments on Kodiak Sciences.
Its momentum is amazing. Any red flags?
Thanks
Dave

Upvote 0

Read Answer Asked by Dave on November 21, 2019

• Amarin Corporation plc (AMRN $15.82)
  • $15.82 Cap: $328M
  • View AMRN Profile
  • View Questions on AMRN

Q: Hi 5i Team,

Today analyst at Oppenheimer issues a report which commented a very bearish take on Amarin
Corp stock , arguing it will fall to 7.00 within 18 months due to higher cost in sale. This resulted a 15% drop at time of writing.

I am holding this stock for a few months , should I hold , sell or buy more?

What is your take? Are you still positive on this stock?

Thank you for your professional advice and assistance as always.







arguing

Upvote 0

Read Answer Asked by Pui on November 20, 2019

• Medtronic plc. (MDT $97.53)
  • $97.53 P/E (TTM): 26.67X Cap: $125.03B
  • View MDT Profile
  • View Questions on MDT

Q: mdt reported today your thoughts please Gary

Upvote 0

Read Answer Asked by gary on November 20, 2019

• Akumin Inc. (AKU $0.53)
  • View AKU Profile
  • View Questions on AKU

Q: Hello, A couple of well-respected advisors have recently recommended this stock on BNN Market Place. I read your opinion on this stock in October which was not positive. Has your opinion changed?

Upvote 0

Read Answer Asked by Alan on November 19, 2019

• BluEnergies Ltd. (BLU)
  • Cap: $86M
  • View BLU Profile
  • View Questions on BLU

Q: Hi 5i Team,
Your comment on Bellus Health’s earning and it’s future outlook please.

Thank you for your professional service and advice as always.

Upvote 0

Read Answer Asked by Pui on November 18, 2019

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Does GUD's precipitous drop in share price indicate that the market believes the acquisition of Biotoscana was not a good investment? How solid is Biotoscana? Are some of their products fit for the US/CDN markets? South American market? Your opinion is always appreciated. Thanks. Gaston

Upvote 0

Read Answer Asked by Gaston on November 18, 2019

• Intuitive Surgical Inc. (ISRG $586.24)
  • $586.24 P/E (TTM): 77.29X Cap: $207.81B
  • View ISRG Profile
  • View Questions on ISRG

Q: I know you have liked this stock in the past. It has been relatively flat over the last year (bouncing up and down) How do you feel about it now and going forward? Is there a better risk/reward trade off in the space?

Thanks!

Upvote 0

Read Answer Asked by Steve on November 15, 2019

• NextCure Inc. (NXTC $13.37)
  • $13.37 Cap: $72M
  • View NXTC Profile
  • View Questions on NXTC

Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.

Upvote 0

Read Answer Asked by Vinod on November 15, 2019

• Amarin Corporation plc (AMRN $15.82)
  • $15.82 Cap: $328M
  • View AMRN Profile
  • View Questions on AMRN

Q: Hi 5i team,

Back to AMRN. I thought they hit a home run yesterday with a unanimous (16 to 0) vote of the Advisory Committee to approve an expanded label use of Vascepa for treating various heart-related conditions, which should give them access to a much larger patient population base. However, the market is not so sure as the response is very muted at least so far today, and that may change. I took a small position to manage risk as I expected a big move one way or the other. I recognize this still has to go to the full FDA in a few weeks, but I understand that the FDA seldom overturns a strong endorsement of the AdCom. Am I missing something here in the muted market response?

Thanks again.
Dave

Upvote 0

Read Answer Asked by Dave on November 15, 2019

• Savaria Corporation (SIS $23.86)
  • $23.86 P/E (TTM): 27.74X Cap: $1.70B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Hi there, it looks like the market likes the results out of Savaria this morning. It's been stuck in a range for quick sometime. Is this the start of a breakout? Would you be comfortable increasing this to a full position from half at this point? Thank you!

Upvote 0

Read Answer Asked by Michael on November 14, 2019

• Savaria Corporation (SIS $23.86)
  • $23.86 P/E (TTM): 27.74X Cap: $1.70B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Please comment on Q.Txs for u usual great services & views

Upvote 0

Read Answer Asked by Peter on November 14, 2019

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: I have a half position in GUD. Would this be a good time to top up to a full position?

Upvote 0

Read Answer Asked by Larry M. on November 13, 2019